Paras Healthcare IPO Opens for Subscription
Paras Healthcare IPO has opened for subscription on October 21, 2026, giving investors an opportunity to invest in a hospital operator focused on specialised and tertiary healthcare services. The company aims to raise ₹1,450 crore through a combination of a fresh issue and an offer for sale (OFS).
The IPO comes amid growing demand for organised healthcare services in India. Paras Healthcare operates hospitals across several cities and focuses on complex medical specialties, including cardiac sciences, oncology, neurosciences and renal care.
Paras Healthcare IPO Details
| Particular | Details |
|---|---|
| IPO Opening Date | October 21, 2026 |
| IPO Closing Date | October 23, 2026 |
| Total Issue Size | ₹1,450 crore |
| Fresh Issue | ₹500 crore |
| Offer for Sale | ₹950 crore |
| Price Band | ₹660–₹693 per share |
| Face Value | ₹1 per share |
| Lot Size | 21 shares |
| Minimum Retail Investment | ₹14,553 |
| Allotment Date | October 26, 2026 (expected) |
| Refund Initiation | October 27, 2026 (tentative) |
| Share Credit to Demat | October 27, 2026 (tentative) |
| Listing Date | October 28, 2026 (tentative) |
| Listing Exchanges | NSE and BSE |
| Registrar | MUFG Intime India |
| Book Running Lead Managers | JM Financial, BofA Securities India and Nuvama Wealth Management |
Retail investors need to apply for at least one lot of 21 shares. At the upper price band of ₹693, the minimum application amount is ₹14,553.
Paras Healthcare IPO GMP Today
As of October 21, 2026, a recent market report places the grey market premium (GMP) at around ₹50 per share. Based on the upper price band of ₹693, this suggests an indicative listing price of ₹743.
| Particular | Details |
|---|---|
| Upper Price Band | ₹693 |
| Reported GMP | Around ₹50 |
| Indicative Listing Price | ₹743 |
| Indicative Premium | Approximately 7.2% |
GMP figures vary between tracking platforms and can change quickly during the IPO period. Grey market premiums are unofficial and do not guarantee listing gains. Investors should not rely on GMP alone when deciding whether to apply.
Fresh Issue and Offer for Sale
The ₹1,450 crore offering comprises a fresh issue of ₹500 crore and an OFS of ₹950 crore. The fresh issue will bring new capital into the company, while the OFS allows existing shareholders to sell part of their holdings.
The company plans to use approximately ₹302.9 crore from the fresh issue to repay or prepay borrowings. Around ₹54.1 crore is earmarked for investment in its wholly owned subsidiary, Paras Medical Holdings Private Limited, with the remaining proceeds intended for general corporate purposes.
About Paras Healthcare
Paras Healthcare is a hospital network that provides specialised healthcare services across multiple regions of India. As of June 30, 2026, the company operated eight hospitals with a combined capacity of 2,211 beds.
Its network serves markets including Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi and Srinagar. The company focuses on complex clinical specialties, including cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and sports injury, and renal sciences.
Its presence across different cities gives the company access to patients seeking specialised medical treatment. Future growth will depend on hospital utilisation, clinical capabilities, expansion plans and the company's ability to manage costs.
Paras Healthcare Financial Performance
Investors should review the company's audited financial statements and prospectus to assess its revenue growth, profitability, borrowings and cash flows. For hospital businesses, important factors include occupancy rates, average revenue per occupied bed, operating margins and the cost of developing or upgrading facilities.
The proposed use of IPO proceeds for debt repayment is an important consideration because it may help reduce borrowing obligations. However, investors should also assess whether the company's operating performance can support future expansion and ongoing capital expenditure.
Key Risks to Consider
Before applying, investors should consider several business risks:
-
High operating costs: Hospitals require skilled medical professionals, modern equipment and continuous infrastructure investment.
-
Competition: Established hospital groups and regional healthcare providers compete for patients, doctors and specialised services.
-
Expansion risks: New facilities and additional beds may take time to reach expected utilisation levels.
-
Regulatory requirements: Healthcare providers must comply with applicable medical, safety, licensing and pricing regulations.
-
Debt and valuation: Investors should assess existing borrowings, profitability and the IPO valuation before making an investment decision.
Paras Healthcare IPO: Important Dates
The subscription window closes on October 23, 2026. The basis of allotment is expected on October 26, followed by tentative refunds and demat share credits on October 27. Listing on the NSE and BSE is scheduled for October 28, 2026.
Applicants should check their allotment status through the registrar or the relevant exchange once the results are available.
Should You Apply for the Paras Healthcare IPO?
Paras Healthcare offers exposure to India's organised healthcare sector through a network of specialised hospitals. Its established hospital footprint and planned debt repayment are relevant factors for investors to examine. However, the final investment decision should also consider valuation, financial performance, competition and expansion risks.
Read the prospectus and compare the company's financial metrics with listed hospital operators before applying. GMP is only an unofficial market indicator and should not be treated as a reliable prediction of listing performance.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. IPO details and GMP may change. Verify the latest information in official exchange filings and the offer document before investing.
Loading comments...